174 related articles for article (PubMed ID: 23134022)
1. [Integrated supportive therapy for multiple myeloma-bone disease treatment, myeloma kidney treatment, cryotherapy, nutrition support team].
Miwa A
Nihon Rinsho; 2012 Apr; 70 Suppl 2():603-27. PubMed ID: 23134022
[No Abstract] [Full Text] [Related]
2. Optimal use of bisphosphonates in patients with multiple myeloma.
Terpos E; Roodman GD; Dimopoulos MA
Blood; 2013 Apr; 121(17):3325-8. PubMed ID: 23407550
[No Abstract] [Full Text] [Related]
3. Therapeutic approaches to myeloma bone disease: an evolving story.
Longo V; Brunetti O; D'Oronzo S; Dammacco F; Silvestris F
Cancer Treat Rev; 2012 Oct; 38(6):787-97. PubMed ID: 22494965
[TBL] [Abstract][Full Text] [Related]
4. Myeloma: diagnosis complications and supportive care.
Morgan G
Hematology; 2012 Apr; 17 Suppl 1():S109-11. PubMed ID: 22507795
[TBL] [Abstract][Full Text] [Related]
5. Bisphosphonate therapy in the treatment of multiple myeloma.
Lawson MA; Ashcroft J; Croucher PI
Curr Pharm Des; 2010; 16(27):3028-36. PubMed ID: 20722619
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic role of bisphosphonate and radiation combination in the management of myeloma bone disease.
Ural AU; Avcu F
Clin Cancer Res; 2007 Jun; 13(11):3432. PubMed ID: 17545554
[No Abstract] [Full Text] [Related]
7. Medical management update: multiple myeloma.
Stoopler ET; Vogl DT; Stadtmauer EA
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 May; 103(5):599-609. PubMed ID: 17291793
[TBL] [Abstract][Full Text] [Related]
8. [Effect of bisphosphonate on myeloma bone disease].
Abe M; Matsumoto T; Kosaka M
Rinsho Ketsueki; 2002 May; 43(5):349-52. PubMed ID: 12096484
[No Abstract] [Full Text] [Related]
9. Advances in the biology and treatment of bone disease in multiple myeloma.
Raje N; Roodman GD
Clin Cancer Res; 2011 Mar; 17(6):1278-86. PubMed ID: 21411443
[TBL] [Abstract][Full Text] [Related]
10. [Management of bone lesions in multiple myeloma].
Hata H; Mitsuya H
Gan To Kagaku Ryoho; 2006 Aug; 33(8):1072-6. PubMed ID: 16912524
[TBL] [Abstract][Full Text] [Related]
11. Novel therapeutic targets in myeloma bone disease.
Webb SL; Edwards CM
Br J Pharmacol; 2014 Aug; 171(16):3765-76. PubMed ID: 24750110
[TBL] [Abstract][Full Text] [Related]
12. [Multiple myeloma].
Abe M
Nihon Rinsho; 2009 May; 67(5):991-5. PubMed ID: 19432122
[TBL] [Abstract][Full Text] [Related]
13. Challenging the current approaches to multiple myeloma- and other cancer-related bone diseases: from bisphosphonates to targeted therapy.
Kleber M; Udi J; Metzke B; Terpos E; Roodmann GD; Morgan G; Dispenzieri A; Einsele H; Wäsch R; Engelhardt M
Leuk Lymphoma; 2012 Jun; 53(6):1057-61. PubMed ID: 22149167
[TBL] [Abstract][Full Text] [Related]
14. [Guidelines for the use of bisphosphonates in multiple myeloma: Recommendations of the expert committee of the Spanish Myeloma Group from the PETHEMA group].
García-Sanz R; Alegre A; Capote FJ; Hernández JM; Rosiñol L; Rubia Jde L; Sureda A; Arriba Fd; Bargay J; Díaz Mediavilla J; García-Laraña J; Lahuerta JJ; Mateos MV; Prósper F; San Miguel J; Bladé J;
Med Clin (Barc); 2010 Mar; 134(6):268-78. PubMed ID: 19863972
[No Abstract] [Full Text] [Related]
15. Therapeutic options in the management of myeloma bone disease.
Berenson JR
Semin Oncol; 2010 Jun; 37 Suppl 1():S20-9. PubMed ID: 20682368
[TBL] [Abstract][Full Text] [Related]
16. Myeloma bone disease and treatment options.
Yeh HS; Berenson JR
Eur J Cancer; 2006 Jul; 42(11):1554-63. PubMed ID: 16797971
[TBL] [Abstract][Full Text] [Related]
17. Serum C terminal telopeptide maintains its correlation with bone disease in patients with myeloma even under treatment with bisphosphonates.
Pochintesta L; Mangiacavalli S; Cocito F; Pompa A; Albertini R; Pascutto C; Ferretti VV; Cazzola M; Corso A
Leuk Lymphoma; 2014 Jun; 55(6):1397-8. PubMed ID: 23931337
[No Abstract] [Full Text] [Related]
18. [Complications and their management in multiple myeloma patients: bone disease, renal impairment and peripheral neuropathy].
Sakai A
Rinsho Ketsueki; 2012 Oct; 53(10):1689-98. PubMed ID: 23037741
[No Abstract] [Full Text] [Related]
19. Biology and treatment of myeloma related bone disease.
Terpos E; Christoulas D; Gavriatopoulou M
Metabolism; 2018 Mar; 80():80-90. PubMed ID: 29175022
[TBL] [Abstract][Full Text] [Related]
20. [Treatment for multiple myeloma: current status and future strategy in Japan].
Iida S
Rinsho Ketsueki; 2008 Oct; 49(10):1368-73. PubMed ID: 18833921
[No Abstract] [Full Text] [Related]
[Next] [New Search]
